30 Sep 2022

Running the London Marathon on Grannie’s birthday

Laura is running in tribute to her beloved grandmother Doreen, who died in 2020. The marathon will take place on Doreen’s birthday.

Doreen, at 91, was diagnosed with Chronic Lymphocytic Leukaemia (CLL) in 2017. Prior to her diagnosis she had no symptoms. She had moved house and joined a new GP surgery which carried out a new patient health check. She believed herself to be fit and active for her age and the diagnosis came as a shock to her and her family.

“When my Grannie was diagnosed my family researched the condition to understand what she was going through and how we could help,” said Laura, who works with vulnerable adults with learning difficulties. “As part of the research, we came across Leukaemia UK. We have supported the charity in memory of my Grannie ever since, greatly valuing the amazing work it does in aiming for better treatments and care for those affected by leukaemia and other blood cancers.

“As a lifelong ambition I have always dreamed of being allocated a place in the London Marathon and am very grateful to Leukaemia UK for giving me this opportunity. The training has (fingers crossed) been going very well. Of course there have been some challenges, but I have tried to stay positive and overcome these with a smile on my face. I have valued advice from previous marathon runners, gradually increased the distance on my training runs and have taken part in the Big Half as a pre-marathon practice.

“Running in memory of Grannie has definitely motivated me throughout my training, forever trying to make her proud. It is really heart-warming that the London Marathon 2022 falls on my Grannie’s Birthday, Sunday 2nd October. She would have been 96, and I know she’ll be with me all the way.”

Doreen received various treatments, including chemotherapy and blood transfusions. Sadly she passed away two and a half years after she was diagnosed.

Laura is not only running to raise money for Leukaemia UK to research new and kinder treatments to stop the disease devastating families. She is also keen to raise awareness about the most common symptoms of leukaemia – fatigue, infections, bleeding and bruising.

“I would advise those who may be concerned about symptoms of leukaemia in themselves or someone they know to ‘get checked straight away, without hesitation or delay’. I feel this motto is something to live by and nothing should be deemed as a silly visit to the doctors. After all it is ‘better to be safe than sorry’.

“I was absolutely devastated when my Grannie was diagnosed and of course heartbroken when she passed away. She would always inspire me to follow my dreams, fulfil my life ambitions and never give up, which has definitely motivated me to take part in the London Marathon 2022 and raise funds and awareness for such an amazing cause.”

Read more stories from our community.

Related posts

Inquiry highlights the impact of COVID-19 on blood cancer services

11 March 2022

Inquiry highlights the impact of COVID-19 on blood cancer services

A new report has recently been published, following an inquiry by the All-Party Parliamentary Group (APPG) on Blood Cancer and the APPG on Stem Cell Transplantation and Advanced Cellular Therapies, on the impact of Covid-19 on blood cancer services in the UK.

Lymphoma: Understanding relapse and treatment resistance

11 January 2019

Lymphoma: Understanding relapse and treatment resistance

Dr Dinis Calado, The Francis Crick Institute and Project Grant Holder

Leukaemia UK John Goldman Fellow awarded Professorship

28 November 2022

Leukaemia UK John Goldman Fellow awarded Professorship

Talented blood cancer researcher, Vignir Helgason, was awarded a Leukaemia UK John Goldman Fellowship in 2015, for his research into chronic myeloid leukaemia (CML). Since then, his research career has…

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

19 February 2024

Leukaemia UK launches new Patient Care Pioneer Award funding initiative

Leukaemia UK is delighted to launch a brand-new funding scheme in 2024, intended specifically for innovative, patient-focussed applied research and targeting UK-based healthcare professionals.   The first of its kind for…